2024/10/18 16:25:08 | |
---|---|
Price | |
2.535 EUR | |
Difference | -1.17% (-0.03) |
ISIN | NL0012047823 |
Symbol | AVTX |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 207 EUR |
Benchmark | AMSTERDAM EXCHANGES INDEX |
Bid (Bid size) | - (0) |
Ask (Ask size) | - (0) |
Open | 2.64 EUR |
High | 2.64 EUR |
Low | 2.52 EUR |
Close (prev. day) | 2.565 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 11 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/09/27 | Global Equity Ratings | ||
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings |
2024/10/18 16:25:08 | |
---|---|
Price | |
2.535 EUR | |
Difference | -1.17% (-0.03) |
ISIN | NL0012047823 |
Symbol | AVTX |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 207 EUR |
Benchmark | AMSTERDAM EXCHANGES INDEX |
Bid (Bid size) | - (0) |
Ask (Ask size) | - (0) |
Open | 2.64 EUR |
High | 2.64 EUR |
Low | 2.52 EUR |
Close (prev. day) | 2.565 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 11 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -1.93% | -3.63% | -24.16% |
Perf (abs.) | -0.05 | -0.10 | -0.81 |
Beta | 1.52 | 1.14 | 1.04 |
Volatility | 55.91 | 54.02 | 51.95 |
Ø price 5 days | Ø volume 5 days (pcs.) | 2.518 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 2.052 EUR (90) |
Ø price 100 days | Ø volume 100 days (pcs.) | 2.303 EUR (36) |
Ø price 250 days | Ø volume 250 days (pcs.) | 2.515 EUR (50) |
YTD High | date | 3.100 EUR (2024/01/17) |
YTD Low | date | 1.584 EUR (2024/09/11) |
52 Weeks High | date | 3.799 EUR (2023/11/23) |
52 Weeks Low | date | 1.584 EUR (2024/09/11) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/10/18 | 22:26 | 2.605 EUR | 0.05 | 27 |
Stuttgart | 2024/10/18 | 16:25 | 2.535 EUR | 0.00 | 11 |
Munich | 2024/10/18 | 08:05 | 2.625 EUR | 0.00 | 2 |
London Stock Exchange | 2024/07/02 | 15:33 | 2.5325 EUR | 0.01 | 1 |
Frankfurt | 2024/10/18 | 20:00 | 2.595 EUR | 0.00 | 8 |
FINRA other OTC Issues | 2024/10/16 | 18:34 | 2.554 USD | 0.00 | 1 |
Euronext Amsterdam | 2024/10/18 | 17:35 | 2.60 EUR | 1.44 | 617 |
Duesseldorf | 2024/10/18 | 19:30 | 2.58 EUR | 0.00 | 6 |
Berlin | 2024/10/18 | 19:33 | 2.60 EUR | 0.00 | 16 |
AVANTIUM NV |
- - |
Zekeringstraat 29 - 1014 BV Amsterdam |
Telefon: +31-20-586-80-80 |
Fax: +31-20-586-80-85 |
E-mail: info@avantium.com |
Avantium NV engages in the development and commercialization of bio-based plastics and chemicals using advanced catalysis research and development. It operates through the following segments: R&D Solutions, Renewable Chemistries, and Renewable Polymers. The R&D Solutions segment provides advanced catalysis research and development services, systems, and testing to global customers. The Renewable Chemistries segment develops PlantMEG, a plant-based alternative for fossil-based mono-ethylene glyco. The Renewable Polymers segment focuses on the commercialization of YXY plants-to-plastics technology. The company was founded February 2000 and is headquartered in Amsterdam, the Netherlands. |
Tom van Aken | Chairman of Managing Board |
Boudewijn van Schaik | Member of Executive Committee |
Edwin Moses | Chairman of Supervisory Board |
Dirk van Meirvenne | Member of Supervisory Board |
Margret Kleinsman | Member of Supervisory Board |
Michelle Jou | Member of Supervisory Board |
Nils Björkman | Member of Supervisory Board |
Peter Williams | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer